Trials / Completed
CompletedNCT01016470
Efficacy of Nutritional Supplement VIUSID/ALZER in Patients With Parkinson's Disease
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Catalysis SL · Industry
- Sex
- All
- Age
- 20 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate whether Viusid/Alzer Nutritional supplements, could improve the progression disease, in patients with Parkinson's Disease (PD).
Detailed description
Periodical measures of the clinical features with UPDRS will be done at the beginning, each three months until two years. Each group will be compare to evaluate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | VIUSID/ALZER | VIUSID/ALZER, 3 per day, oral, one year |
| DIETARY_SUPPLEMENT | Placebo | Placebo Viusid and Placebo Alzer, 3 per day, oral, one year |
Timeline
- Start date
- 2009-10-01
- Primary completion
- 2011-05-01
- Completion
- 2011-05-01
- First posted
- 2009-11-19
- Last updated
- 2012-05-04
Locations
1 site across 1 country: Cuba
Source: ClinicalTrials.gov record NCT01016470. Inclusion in this directory is not an endorsement.